Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-25-008044
Filing Date
2025-02-24
Accepted
2025-02-24 16:05:31
Documents
70

Document Format Files

Seq Description Document Type Size
1 form424b3.htm   iXBRL 424B3 2230782
2 form424b3_001.jpg GRAPHIC 14477
3 form424b3_002.jpg GRAPHIC 29831
4 form424b3_003.jpg GRAPHIC 41307
5 form424b3_004.jpg GRAPHIC 32595
6 form424b3_005.jpg GRAPHIC 29745
  Complete submission text file 0001493152-25-008044.txt   7089124

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE scnx-20240630.xsd EX-101.SCH 34092
8 XBRL CALCULATION FILE scnx-20240630_cal.xml EX-101.CAL 48822
9 XBRL DEFINITION FILE scnx-20240630_def.xml EX-101.DEF 275193
10 XBRL LABEL FILE scnx-20240630_lab.xml EX-101.LAB 255717
11 XBRL PRESENTATION FILE scnx-20240630_pre.xml EX-101.PRE 290934
73 EXTRACTED XBRL INSTANCE DOCUMENT form424b3_htm.xml XML 973750
Mailing Address 2420 BRUNELLO TRACE LUTZ FL 33558
Business Address 2420 BRUNELLO TRACE LUTZ FL 33558 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-283591 | Film No.: 25656961
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)